Global Infection prevention & Control Market Analysis & Forecast 2014-2020, With an Expected CAGR of 5.3% - ResearchAndMarkets.com

June 13, 2018

DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The “Infection prevention & Control Market: By Infections; By Antimicrobial Drugs; By Accessories & Equipment; By End User & By Geography - Forecast 2014-2020” report has been added to ResearchAndMarkets.com’s offering.

Infection prevention and Control (IPC) is a rapidly growing field in the healthcare industry. The proper usage of the IPC products all across the globe has the potential to revolutionize the complete healthcare industry, making it disease free. The market opportunity for IPC is promising, yet conflicting financial Incentives has created uncertainty on how stakeholders can capitalize. The market for Infection prevention is estimated to increase with a CAGR of 5.3% during the forecast period 2015-2020.

Infection prevention and control is the major and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals, and food & beverage industries. The adoption of various means of personal protective equipment, disinfection, sterilization and in-house sterilization procedures by hospitals and end users industries has revolutionized the healthcare industry. Sterilization and disinfection protect different products and materials from being contaminated by microbes. The disinfection and sterilization market is going to expand with a CAGR of 6.2% during the period under study.

The North American region has been concentrating on relatively easy commercial drugs which were driven by the increase in chronic diseases. This has led to the development of vaccines, since these are specific for a particular infection. The cost of the vaccines varies as per the infected microbes. Thus, followed by anti-bacterial drugs, vaccines show the highest growth rate of 4.8% towards the increasing demand of anti-microbial drugs, where most patients would be managed with a short course of therapy in comparison to the generic antibiotics.

Companies Mentioned:

Abbott Laboratories (Abbott Diacnostics) Alere Ansell Limited Astrazenecea Bard (CR) Incorporated Becton, Dickinson And Company Belimed Cantel Covidien Plc Getinge Group Hollister Incorporated Johnson & Johnson Kimberly-Clark Merck & Co Pfizer Roche Siemens Ag Supermax Corporation Terumo Corporation 3M Company

Key Topics Covered:

1. Global Infection Prevention & Control - Market Overview

2. Global Infection Prevention & Control Market - Executive Summary

3. Global Infection Prevention & Control - Market Landscape

4. Global Infection Prevention & Control - Market Forces

5. Global Infection Prevention & Control Market - Strategic Analysis

6. Global Infection Prevention & Control Market - By Infections

7. Global Infection Prevention & Control Market - By Anti-Microbial Drugs

8. Infection Prevention & Control Market - By Accessories and Equipment

9. Global Infection Prevention & Control Market - By End User Industry

10. Global Infection Prevention & Control Market - Regulatory Scenario

11. Global Infection Prevention & Control Market - Geographic Analysis

12. Market Entropy

13. Company Profiles

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/nmk8sx/global_infection?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005495/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs,Infectious Disease Testing,Antibiotics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/13/2018 06:21 AM/DISC: 06/13/2018 06:21 AM


Update hourly